Prifelone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H24O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0414BW860U, chemically known as 3,5-di-tert-butyl-4-hydroxyphenyl 2-thienyl ketone but generally known as prifelone, which bears US NIH Compound Identifier 71751. European Medicines Agency schedules Prifelone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10038MIG. The term PRIFELONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). PRIFELONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prifelone under HS 29349990 and SITC 51579. As of Q4 2014, PRIFELONE remains the US FDA Preferred Term for this commodity. Prifelone bears US NLM identifiers UMLS ID C0618049 and NCI Concept Code C80567. SMILES: S1C(C(=O)C2CC(C(C)(C)C)C(O)C(C(C)(C)C)C2)CCC1.